300 related articles for article (PubMed ID: 11099414)
41. Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax.
Jia L; Patwari Y; Kelsey SM; Newland AC
Biochem Biophys Res Commun; 2001 May; 283(5):1037-45. PubMed ID: 11355877
[TBL] [Abstract][Full Text] [Related]
42. Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells.
Sarker M; Ruiz-Ruiz C; Robledo G; López-Rivas A
Oncogene; 2002 Jun; 21(27):4323-7. PubMed ID: 12082620
[TBL] [Abstract][Full Text] [Related]
43. Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3.
Degli Esposti M; Ferry G; Masdehors P; Boutin JA; Hickman JA; Dive C
J Biol Chem; 2003 May; 278(18):15749-57. PubMed ID: 12598529
[TBL] [Abstract][Full Text] [Related]
44. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
45. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain.
Cowling V; Downward J
Cell Death Differ; 2002 Oct; 9(10):1046-56. PubMed ID: 12232792
[TBL] [Abstract][Full Text] [Related]
46. Dynamic interaction of cBid with detergents, liposomes and mitochondria.
Bleicken S; García-Sáez AJ; Conte E; Bordignon E
PLoS One; 2012; 7(4):e35910. PubMed ID: 22540011
[TBL] [Abstract][Full Text] [Related]
47. Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis.
Kim JY; Kim YH; Chang I; Kim S; Pak YK; Oh BH; Yagita H; Jung YK; Oh YJ; Lee MS
Oncogene; 2002 May; 21(20):3139-48. PubMed ID: 12082629
[TBL] [Abstract][Full Text] [Related]
48. Ion channel activity of the BH3 only Bcl-2 family member, BID.
Schendel SL; Azimov R; Pawlowski K; Godzik A; Kagan BL; Reed JC
J Biol Chem; 1999 Jul; 274(31):21932-6. PubMed ID: 10419515
[TBL] [Abstract][Full Text] [Related]
49. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
Kuwana T; Bouchier-Hayes L; Chipuk JE; Bonzon C; Sullivan BA; Green DR; Newmeyer DD
Mol Cell; 2005 Feb; 17(4):525-35. PubMed ID: 15721256
[TBL] [Abstract][Full Text] [Related]
50. Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death.
Kominsky DJ; Bickel RJ; Tyler KL
Cell Death Differ; 2002 Sep; 9(9):926-33. PubMed ID: 12181743
[TBL] [Abstract][Full Text] [Related]
51. Confirmation by FRET in individual living cells of the absence of significant amyloid beta -mediated caspase 8 activation.
Onuki R; Nagasaki A; Kawasaki H; Baba T; Uyeda TQ; Taira K
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14716-21. PubMed ID: 12409609
[TBL] [Abstract][Full Text] [Related]
52. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
53. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production.
Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM
Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620
[TBL] [Abstract][Full Text] [Related]
54. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis.
Yin XM; Wang K; Gross A; Zhao Y; Zinkel S; Klocke B; Roth KA; Korsmeyer SJ
Nature; 1999 Aug; 400(6747):886-91. PubMed ID: 10476969
[TBL] [Abstract][Full Text] [Related]
55. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species.
Ruefli AA; Ausserlechner MJ; Bernhard D; Sutton VR; Tainton KM; Kofler R; Smyth MJ; Johnstone RW
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10833-8. PubMed ID: 11535817
[TBL] [Abstract][Full Text] [Related]
56. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists.
McDonnell JM; Fushman D; Milliman CL; Korsmeyer SJ; Cowburn D
Cell; 1999 Mar; 96(5):625-34. PubMed ID: 10089878
[TBL] [Abstract][Full Text] [Related]
57. Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events.
Vilas GL; Corvi MM; Plummer GJ; Seime AM; Lambkin GR; Berthiaume LG
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6542-7. PubMed ID: 16617111
[TBL] [Abstract][Full Text] [Related]
58. A role for N-myristoylation in protein targeting: NADH-cytochrome b5 reductase requires myristic acid for association with outer mitochondrial but not ER membranes.
Borgese N; Aggujaro D; Carrera P; Pietrini G; Bassetti M
J Cell Biol; 1996 Dec; 135(6 Pt 1):1501-13. PubMed ID: 8978818
[TBL] [Abstract][Full Text] [Related]
59. Roles of Protein N-Myristoylation and Translational Medicine Applications.
Xu M; Xie L; Yu Z; Xie J
Crit Rev Eukaryot Gene Expr; 2015; 25(3):259-68. PubMed ID: 26558949
[TBL] [Abstract][Full Text] [Related]
60. The biology and enzymology of protein N-myristoylation.
Farazi TA; Waksman G; Gordon JI
J Biol Chem; 2001 Oct; 276(43):39501-4. PubMed ID: 11527981
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
